Skip to main content
Elsevier

Pioneering Precision in Cancer Treatment through 3D Bioprinting

  • 1st Edition - November 1, 2026
  • Latest edition
  • Editors: Anand Krishnan, Mamello Sekhoacha, Parks Makhoahle, Arun Kumar Singh
  • Language: English

Pioneering Precision in Cancer Treatment through 3D Bioprinting explores the transformative impact of 3D bioprinting on cancer therapy. This groundbreaking book examines innova… Read more

Description

Pioneering Precision in Cancer Treatment through 3D Bioprinting explores the transformative impact of 3D bioprinting on cancer therapy. This groundbreaking book examines innovative techniques revolutionizing cancer care, from creating patient-specific tumor models to accelerating drug discovery and enabling personalized treatments. It offers a comprehensive look at how 3D bioprinting is reshaping oncology. The book details the creation of intricate tumor models that mimic the in vivo environment, enabling precise drug testing and individualized treatment plans. It highlights 3D bioprinting's role in drug screening, tumor modeling, and creating implantable scaffolds for cancer treatment. By manipulating cell arrangements and microenvironments, 3D bioprinting produces accurate cancer models. For the academic audience, this book blends bioengineering, medical insights, and real-world applications. It provides valuable case studies and developments in 3D cancer model creation, enhancing the understanding of oncogenesis, tumor progression, and therapy responses. Pioneering Precision in Cancer Treatment through 3D Bioprinting is an essential resource for advancing knowledge in personalized cancer care.

Key features

  • Examines cutting-edge methods in 3D bioprinting that revolutionize cancer care, including patient-specific tumor models and personalized treatments
  • Offers in-depth analysis of the creation and application of intricate tumor models, enhancing the accuracy of drug testing and treatment planning
  • Integrates bioengineering, medical insights, and real-world applications, making it a valuable resource for understanding the future of personalized cancer therapy

Readership

Academic professionals, including researchers, clinicians, and students in the fields of oncology, bioengineering, and medical sciences

Table of contents

1. An Overview of 3D Bioprinting in Cancer Therapy

1. An Overview of 3D Bioprinting in Cancer Therapy

2. 3D Bioprinted Cancer Models: Bridging Basic Biology and Drug Development

3. Advancing Anti-Cancer Therapy: The Role of Three-Dimensional (3D) Bioprinting

4. 3D Printing for Cancer Diagnosis and Treatment monitoring

5. 3D printing: Biological printing ink, printing method for Cancer Therapy

6. 3D Printing in Biomedicine: Transforming Personalized Cancer Care

7. 3D Bioprinting Technology for tumor Cell Modelling and Tumor Therapy

8. Biomaterials Integrated 3D Bioprinting: Transforming High-Throughput Drug Screening in Cancer Therapy

9. Tissue Engineering with 3D Bioprinting: Pioneering the Future of Cancer Therapy

10. Therapeutic Precision: Harnessing 3D Printing for Drug Delivery for Cancer Therapy

11. Combinational Gene Therapy for Cancer: Nanoplatform-Based Strategies and Principles

12. Gene Therapy and Bioprinting Synergy for cancer immunotherapy

13. Innovations in 3D Bioprinting: Shaping the Future of Cancer Biology and Precision Medicine

14. In silico techniques, artificial intelligence, and machine learning for 3D Bioprinting in Oncology

15. Clinical trials, regulatory frameworks, and ethical considerations surrounding 3D bioprinting in cancer treatment

16. Current and Future Perspective of 3D Bioprinting in Oncology

Product details

  • Edition: 1
  • Latest edition
  • Published: November 1, 2026
  • Language: English

About the editors

AK

Anand Krishnan

Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.

Affiliations and expertise
Precision Medicine and Integrated Nano-Diagnostics (P-MIND) Research Group, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa

MS

Mamello Sekhoacha

Professor Mamello Sekhoacha is an Associate Professor of Pharmacology at the University of the Free State and a former Specialist Scientist at the South African Medical Research Council. She earned her Ph.D. in Pharmacology from the University of Cape Town in 2008 and holds a BSc in Biochemistry and Microbiology, an honors degree in Pharmacology, and a Postgraduate Diploma in Business Administration. Additionally, she is a qualified Clinical Research Associate (CRA) with expertise in Ethics and Governance and Executive Leadership in Academia.

With over 18 years in pharmacology research, Prof. Sekhoacha focuses on drug discovery and the scientific development of medicinal plants for treating ailments like cancer and HIV. Her research addresses challenges in chemoresistance and toxicity, exploring personalized chemotherapy and targeted drug delivery systems. She has published extensively in pharmacology and biomedical sciences and has held leadership roles in national health research ethics, including chairing the National Health Research Ethics Council.

Affiliations and expertise
University of Free-State, South Africa

PM

Parks Makhoahle

Prof. Parks Makhoahle is a distinguished member of the Golden Key International Honour Society. He earned his BSc in Microbiology and Biotechnology, B.Med.Sc Hons, and M.MedSc in Medical Microbiology and Virology from the University of Free State, along with a D.H.Sc in Biomedical Technology and a PGDIPHE from the Central University of Technology. Currently, he is pursuing a second doctorate in educational studies and serves as the interim Director of the Centre for Quality of Health and Living. His research focuses on the anti-cancer properties of natural products, genotoxicity, and preventing mycotoxin-induced carcinogenicity, collaborating with UFS, NHLS, and WHO-Lesotho. With over 30 peer-reviewed publications and a book chapter, he supervises nine master's students and two PhD candidates. A registered medical biological scientist, he is also a reviewer for NRF and a recipient of the multi-Vice-Chancellor’s Awards, contributing to the establishment of CUT’s advanced Biochemistry and Tissue Culture facility.
Affiliations and expertise
University of Free-State, South Africa

AS

Arun Kumar Singh

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran , India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.
Affiliations and expertise
Assistant Professor, University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, Tehsil Kharar, Distt. Mohali, Punjab-140104, INDIA